title: Post-marketing study on the safety of a meningococcal group A, C bivalent polysaccharide conjugate vaccine.
authors.affiliation: Guangzhou Center for Disease Control and Prevention; Guangzhou, PR China.
authors.forename: Chuanxi
authors.initials: C
authors.lastname: Fu
authors.affiliation: Guangzhou Center for Disease Control and Prevention; Guangzhou, PR China.
authors.forename: Guihua
authors.initials: G
authors.lastname: Huang
authors.affiliation: Guangzhou Center for Disease Control and Prevention; Guangzhou, PR China.
authors.forename: Min
authors.initials: M
authors.lastname: Cui
authors.affiliation: Guangzhou Center for Disease Control and Prevention; Guangzhou, PR China.
authors.forename: Ming
authors.initials: M
authors.lastname: Wang
mesh_terms: D002675:Child, Preschool; D002681:China / Q000453:epidemiology; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology* / Q000473:pathology*; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000517:prevention & control*; D022401:Meningococcal Vaccines / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology*; D011135:Polysaccharides, Bacterial / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology*; D011358:Product Surveillance, Postmarketing
chemical_list: C094429:Mencevax AC; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial
keywords: China; adverse reactions; meningococcal meningitis; safety; vaccine